Our client offers a disruptive line of transparent antiviral masks and respirators that improve protection without compromising comfort, compliance, and human connectivity.
Fourteen worldwide patents and patents pending protect four fully developed products and seven product lines for reusable and disposable respirators and surgical mask products.
These reusable and disposable product lines include detachable protective eye shields, clip-on temple bars and detachable magnification lenses; disposable surgical masks, disposable surgical respirators, and reusable surgical respirators, (with or without protective eyewear) plus other accessories.
Medical providers have long deployed surgical masks and respirators to reduce infections caused by airborne pathogens.
The Covid pandemic drove masks and respirators onto the world stage.
While N95 respirators and surgical masks protect wearers, professionals, and civilians, all have had to accept pragmatic problems.
These deficiencies are not just nuisances, they reduce usage, compliance, and efficacy. These include oxygen deprivation, skin irritation and damage, headache reactions, ineffective filtration, and ophthalmic and otolaryngologic distress.
Our client’s revolutionary products will directly address each of these issues.
Beyond these pragmatic issues, current product offerings are an imposing impairment to human connection.
Studies have shown that patient disposition is affected by facial expressions received from doctors and medical staff.
A masked face is not a friendly one.
Yet, we have accepted the human disruption of current commodity offerings.
Our client believes a better way to protect humanity is with products that protect people without interrupting the human and social connectivity between people, at work, in life, or in healthcare when they are likely to be in a vulnerable position, individually or collectively.
Our client, after having developed the R&D for its transformational line of surgical masks and respirators and given the criticality of such solutions to the marketplace, is seeking a large manufacturer and/or distributor to partner with instead of pursuing a more typical start-up path.
In this case, existing products are so highly commoditized, that a significant opportunity exists for a company to leverage its manufacturing, marketing, distribution, and other assets and capabilities to seize and scale the opportunity.
Our client understands that this approach likely reduces its financial payoff.
Our client wishes to sell all its intellectual assets, designs, patents, etc. to a leader (or prospective leader) who shares its vision for the industry.
After the sale, the founder and developer are willing to continue engaging with the project to continue R&D and design work if desired by the acquiring organization.
He has dozens of patents and is well-known in the industry.
This opportunity is not yet operating and generating revenue.
However, our client has developed four products which include seven product lines with or without protective eyewear. These include disposable surgical masks, disposable surgical respirators, and reusable surgical respirators, with or without protective eyewear (and other accessories).
According to numerous scientific studies and consistent feedback from those in the medical field, there are many well-known issues with today’s mask offerings.
Our client set out to solve these problems and has designed the best respirator and mask product lines.
NDA is required to secure a comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners.
